This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Emdeon And CAQH Announce Plans To Transfer U.S. Healthcare Efficiency Index

Stocks in this article: EM

WASHINGTON and NASHVILLE, Tenn., Sept. 26, 2011 /PRNewswire/ -- CAQH and Emdeon Inc. (NYSE: EM) today announced that they have reached an agreement for Emdeon to transfer ownership and management of the U.S. Healthcare Efficiency Index® (USHEI) to CAQH.

Emdeon, a leading provider of healthcare revenue and payment cycle management and clinical information exchange solutions, created the USHEI in 2008 as an industry forum for monitoring business efficiency in healthcare. It provides a national reference to track and measure the adoption of electronic medical transactions including claims and payment. Today, only an estimated 40 percent of the approximately 13 billion administrative transactions conducted each year are conducted electronically. Completing the conversion from the current paper-based claims payments system to an electronic one is estimated to save more than $30 billion annually across the U.S. healthcare industry.

"We believe CAQH is a perfect strategic home for the USHEI," said Miriam Paramore, senior vice president of clinical services for Emdeon. "For over a decade CAQH has championed proven healthcare simplification solutions that deliver quantifiable results. Under its stewardship, the USHEI can be expanded to provide a more comprehensive view of these results, including achievements that are being accelerated by the adoption of new transaction standards and operating rules contained in the healthcare reform law."

CAQH is a leader in the development and implementation of innovative solutions for simplifying healthcare administration. CAQH plans to add aggregated outcomes data from current CAQH sponsored initiatives, including the Committee on Operating Rules for Information Exchange® (CORE®), into the USHEI. The addition of this data will enable CAQH to offer a robust analysis of the progress being made from paper-based transactions to more efficient and cost effective electronic transactions.

"We are excited to build upon Emdeon's success and take the USHEI to the next level by drawing upon our experience in streamlining data collection and information exchange," said Robin Thomashauer, executive director of CAQH. "The inclusion of aggregated data from the CAQH initiatives will help to enhance the USHEI by clearly and continuously measuring the increasing efficiency of healthcare administration."

The USHEI was designed as an industry-wide outlet for tracking the transition from a paper- and phone-based healthcare system to an electronic one. An independent Advisory Council was established to govern the USHEI and was responsible for overseeing the effort, developing the data collection methodology and reporting on progress across the healthcare industry. The USHEI will continue to serve as a central reference for tracking progress and the cost savings associated with electronic adoption, including the transactions called for by the healthcare reform law.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,618.62 +261.75 1.51%
S&P 500 2,043.63 +30.74 1.53%
NASDAQ 4,719.1310 +74.8190 1.61%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs